Page last updated: 2024-08-21

pyrazines and Chickungunya Fever

pyrazines has been researched along with Chickungunya Fever in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Dagley, A; Furuta, Y; Gebre, M; Julander, JG; Komeno, T; Nakajima, N; Smee, DF1
Bello, F; Dallmeier, K; de Lamballerie, X; Delang, L; Froeyen, M; Herdewijn, P; Jochmans, D; Leyssen, P; Martina, B; Neyts, J; Pastorino, B; Quérat, G; Segura Guerrero, N; Snijder, EJ; Tas, A; van Hemert, MJ1

Other Studies

2 other study(ies) available for pyrazines and Chickungunya Fever

ArticleYear
Strain-dependent disease and response to favipiravir treatment in mice infected with Chikungunya virus.
    Antiviral research, 2020, Volume: 182

    Topics: Amides; Animals; Antiviral Agents; Cell Line; Chikungunya Fever; Chikungunya virus; Female; Genotype; Humans; Mice; Mice, Inbred DBA; Phenotype; Phylogeny; Pyrazines

2020
Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:10

    Topics: Amides; Animals; Antiviral Agents; Cell Line; Chikungunya Fever; Chikungunya virus; Cytopathogenic Effect, Viral; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Viral; Mice; Microbial Sensitivity Tests; Mutation; Phenotype; Pyrazines; Reproducibility of Results; Viral Nonstructural Proteins; Virus Replication

2014